View conference programme - The British Society for Rheumatology

324 CHARACTERIZATION OF AUTOREACTIVE IL-4 PRODUCING T CELLS ISOLATED FROM
PATIENTS WITH SPONDYLOARTHROPATHY (SpA).
LB Jarvis, MK Matyszak, JSH Gaston. Department of Medicine, University of Cambridge,
Cambridge, United Kingdom
325 PHENOTYPIC CHARACTERIZATION OF NATURAL KILLER CELLS AND RECEPTORS IN
SPONDYLOARTHRITIS.
ATY Chan, S Kollnberger, A McMichael, P Bowness. Human Immunology Unit, Weatherall Institute
of Molecular Medicine, Oxford, United Kingdom
326 METHOTREXATE TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS INCREASES
APOPTOSIS THROUGH DECREASE OF Bcl-2 PRODUCTION AND ACTIVATION OF CASPASE-3.
MJ Benito, B Bresnihan, D Kane, O FitzGerald. Rheumatology, St. Vincent’s University Hospital,
Dublin, Ireland
327 OSTEOPROTEGERIN (OPG) AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR
KAPA-BETA-LIGAND (RANKL) IN THE SERA OF PATIENTS WITH ANKYLOSING SPONDYLITIS (AS):
CORRELATIONS WITH METROLOGY, FUNCTIONAL AND ACTIVITY INDEXES.
A Cauli, G Dessole, R Pala, A Vacca, A Mameli, G Passiu, A Mathieu. 2nd Rheumatology Unit,
University of Cagliari, Cagliari, Italy
SPONDYLARTHROPATHIES: THERAPY (328 – 331)
328 INFLIXIMAB IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF ACTIVE
ANKYLOSING SPONDYLITIS: A DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL USING
MAGNETIC RESONANCE IMAGING.
H Marzo-Ortega 1 , D Mc Gonagle 1,2 , S Jarrett 1 , G Haugeberg 3 , E Hensor 1 , P O’Connor 4 , AL Tanv, PG
Conaghan 1 , A Greenstein 1 , P Emery 1 . 1
Academic Unit of Musculoskeletal Disease, Department of
Rheumatology, University of Leeds, Leeds, West Yorkshire, United Kingdom; 2 Department of
Rheumatology, Calderdale General Hospital, Halifax, West Yorkshire, United Kingdom; 3 Oslo City
Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; 4 Department of Radiology,
Leeds General Infirmary, Leeds, West Yorkshire, United Kingdom
329 AN OPEN STUDY OF PULSE PAMIDRONATE THERAPY IN SEVERE ANKYLOSING
SPONDYLITIS, AND ITS EFFECT ON BIOCHEMICAL MARKERS OF BONE TURNOVER.
AP Cairns 1 , SA Wright 1 , AJ Taggart 1 , SM Coward 2 , GD Wright 1 . 1
Department of Rheumatology,
Musgrave Park Hospital, Belfast, Northern Ireland, United Kingdom; 2 Department of Biochemistry,
Musgrave Park Hospital, Belfast, Northern Ireland, United Kingdom
330 A CLINICAL AND MAGNETIC RESONANCE IMAGING ASSESSMENT OF THE EFFICACY
OF INFLIXIMAB AT A DOSE OF 3MG/KG IN COMBINATION WITH METHOTREXATE IN THE
TREATMENT OF PSORIATIC ARTHRITIS.
H Marzo-Ortega 1 , D Mc Gonagle 1,2 , AL Tan 1 , L Rhodes 3 , S Tanner 3 , PG Conaghan 1 , P O’Connor 4 ,
A Fraser 1 , D Veale 5 , P Emery 1 . 1
Academic Unit of Musculoskeletal Disease, University of Leeds,
Leeds, West Yorkshire, United Kingdom; 2 Department of Rheumatology, Calderdale General
Hospital, Halifax, West Yorkshire, United Kingdom; 3 Academic Unit of Medical Physics, Leeds
General Infirmary, Leeds, West Yorkshire, United Kingdom; 4 Department of Radiology, Leeds
General Infirmary, Leeds, West Yorkshire, United Kingdom; 5 Department of Rheumatology,
St Vincent’s University Hospital, Dublin, Ireland
331 ANTI-TNFα THERAPY IN PSORIASIS AND PSORIATIC ARTHRITIS: CLINICAL AND
ANGIOGENIC RESPONSES.
T Markham 1 , U Fearon 1 , S Rogers 2 , L Golden-Mason 3 , B Bresnihan 1 , O FitzGerald 1 , DJ Veale 1 .
1
Rheumatology, St. Vincents University Hospital and The Conway Institute, Dublin, Ireland;
2
Dermatology, ST. Vincents University Hospital, Dublin, Ireland; 3 Liver Unit, St.Vincents University
Hospital, Dublin, Ireland
69